EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Acetazoleamide a new oral diuretic in congestive cardiac failure


, : Acetazoleamide a new oral diuretic in congestive cardiac failure. Jour Postgrad Med [Bombay] 2(3): 137-148

The present report considers the use of acetazoleamide (Diamox) in 7 patients with congestive cardiac failure and generalized anasarca. The diuresis caused by acetazoleamide and corresponding weight loss and symptomatic improvement was good. Toxic effects encountered were drowsiness and a sense of weakness towards the latter part of the day, which, however, were not severe enough to necessitate withdrawal of the drug. In one case subconjunctival edema and hemorrhage was seen which was ascribed to hypersensitivity to the drug. Diamox is valuable as a diuretic provided it is used correctly.


Accession: 029857612

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Wooster, A.G.; Lockett, M.F.; Curnow, D.H.; Joske, R.A., 1966: The pharmacology of an oral diuretic ("Doburil") in congestive cardiac failure: a comparison with hydrochlorothiazide. Medical Journal of Australia 2(14): 633-635

Farless, L.B.; Steil, N.; Williams, B.Rosa.; Bailey, F.Amos., 2016: Intermittent subcutaneous furosemide: parenteral diuretic rescue for hospice patients with congestive heart failure resistant to oral diuretic. Patients with congestive heart failure (CHF) account for up to 12% of the hospice population and often experience significant symptoms related to volume overload. Diuretic therapy is the cornerstone of treatment but administration (PO) often becom...

Anonymous, 2013: Intermittent Subcutaneous Furosemide Parentral Diuretic Rescue for Hospice Patients with Congestive Heart Failure Resistant to Oral Diuretic. Patients with congestive heart failure (CHF) account for up to 12% of the hospice population and often experience significant symptoms related to volume overload. Diuretic therapy is the cornerstone of treatment but administration (PO) often becom...

Belsky, H., 1953: Use of a new oral diuretic, diamox, in congestive heart failure. New England Journal of Medicine 249(4): 140-143

Douglas, A.H.; Samuel, P.; Wagner, W.P.; Gubernick, I., 1957: Aminoisometradine (rolicton) as an oral diuretic in congestive heart failure. New York State Journal of Medicine 57(22): 3631-3634

Doherty, J.E.; Beard, O.W.; Sadik, H., 1954: The management of congestive heart failure with an oral mercurial diuretic. This study presents a method of treatment, indications, contraindications, toxicity, reactions, therapeutic effect and some special points relative to the use of Neohydrin as the preferred oral mercurial diuretic. Forty-four of 58 patients exhibit...

Allman, S.; Norris, R.J., 1990: An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study. A total of 71 patients with cardiac failure requiring diuretic treatment were randomly allocated to receive either 20 mg frusemide/2.5 mg amiloride or 0.25 mg cyclopenthiazide/8.1 mmol sustained release potassium once daily for 12 weeks. Of the 35...

Allman S.; Norris R.J., 1990: An open parallel group study comparing a frusemide amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure a multicenter general practice study. A total of 71 patients with cardiac failure requiring diuretic treatment were randomly allocated to receive either 20 mg frusemide/2.5 mg amiloride or 0.25 mg cyclopenthiazide/8.1 mmol sustained release potassium once daily for 12 weeks. Of the 35...

Roja, V.Llegas, F.; De.C.Mpo, E.; Brailovsky, D.; Mimica, J., 1954: Preliminary trials with a new oral diuretic: acetazoleamide (diamox). La Semana Medica 31(Anniversary Ed): 119-124

Mehta, S.; Vijayakumar, M., 2010: Complications during enalapril and diuretic therapy for congestive cardiac failure. Indian Journal of Pediatrics 76(9): 963-964